These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31479617)

  • 1. Influenza A Virus Subpopulations and Their Implication in Pathogenesis and Vaccine Development.
    Ghorbani A; Ngunjiri JM; Lee CW
    Annu Rev Anim Biosci; 2020 Feb; 8():247-267. PubMed ID: 31479617
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Hughes HR; Brockmeier SL; Loving CL
    Front Immunol; 2018; 9():2255. PubMed ID: 30337924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA.
    Gould PS; Easton AJ; Dimmock NJ
    Viruses; 2017 Sep; 9(10):. PubMed ID: 28934167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an Alternative Modified Live Influenza B Virus Vaccine.
    Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGL2017-82570-RReverse genetics approaches for the development of new vaccines against influenza A virus infections.
    Martinez-Sobrido L; DeDiego ML; Nogales A
    Curr Opin Virol; 2020 Oct; 44():26-34. PubMed ID: 32599532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide identification of interferon-sensitive mutations enables influenza vaccine design.
    Du Y; Xin L; Shi Y; Zhang TH; Wu NC; Dai L; Gong D; Brar G; Shu S; Luo J; Reiley W; Tseng YW; Bai H; Wu TT; Wang J; Shu Y; Sun R
    Science; 2018 Jan; 359(6373):290-296. PubMed ID: 29348231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
    Ramirez A; Morris S; Maucourant S; D'Ascanio I; Crescente V; Lu IN; Farinelle S; Muller CP; Whelan M; Rosenberg W
    Vaccine; 2018 Feb; 36(6):873-880. PubMed ID: 29306508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.
    Waring BM; Sjaastad LE; Fiege JK; Fay EJ; Reyes I; Moriarity B; Langlois RA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    Crank MC; Mascola JR; Graham BS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S107-S109. PubMed ID: 30715413
    [No Abstract]   [Full Text] [Related]  

  • 11. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2017 Mar; 92(12):129-44. PubMed ID: 28337863
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and vaccination of influenza A virus in swine.
    Rajao DS; Anderson TK; Gauger PC; Vincent AL
    Curr Top Microbiol Immunol; 2014; 385():307-26. PubMed ID: 25033752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learning from our foes: a novel vaccine concept for influenza virus.
    Palese P; Muster T; Zheng H; O'Neill R; Garcia-Sastre A
    Arch Virol Suppl; 1999; 15():131-8. PubMed ID: 10470274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.
    Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30545063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2016 Mar; 91(11):133-43. PubMed ID: 26995804
    [No Abstract]   [Full Text] [Related]  

  • 17. Population Diversity and Collective Interactions during Influenza Virus Infection.
    Brooke CB
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28855247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
    Rudraraju R; Mordant F; Subbarao K
    J Infect Dis; 2019 Apr; 219(Suppl_1):S81-S87. PubMed ID: 30715386
    [No Abstract]   [Full Text] [Related]  

  • 19. In Vivo Models for Pathotyping and Vaccine Efficacy for Swine Influenza.
    Lager KM; Vincent AL
    Methods Mol Biol; 2020; 2123():345-351. PubMed ID: 32170700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of different DNA vaccines for protection of experimental influenza A virus infection.
    Wiesener N; Schütze T; Lapp S; Lehmann M; Jarasch-Althof N; Wutzler P; Henke A
    Viral Immunol; 2011 Aug; 24(4):321-30. PubMed ID: 21830903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.